Four doses of coronavirus disease 2019 vaccination for patients with inborn errors of immunity compared to 3 doses for healthy individuals. [PDF]
Chan JCH +19 more
europepmc +1 more source
A predictive model for rapid assessment of protective efficacy against emerging SARS-CoV-2 variants. [PDF]
Jin L +5 more
europepmc +1 more source
Modeling of antibody waning after heterologous boosting with Ad5-nCoV in individuals primed with two-dose CoronaVac previously. [PDF]
Shen R +5 more
europepmc +1 more source
Seroprevalence, immune response dynamics, and incidence of COVID-19 after CoronaVac vaccination in a fully vaccinated small municipality in Northeast Brazil: a population-based surveillance study. [PDF]
Costa LB +9 more
europepmc +1 more source
Antibody response to different COVID-19 vaccine regimes: a review [PDF]
COVID-19 pandemic initiated a race for the development of vaccines. Different technologies have been used to produce them, including inactivated whole-virus, nucleic acid, and adenovirus vector platforms. COVID-19 vaccination was initiated with two doses
Araujo, Fernanda Montenegro de Carvalho +5 more
core +1 more source
Indirect protection and long-term effectiveness of inactivated COVID-19 vaccine: a stepped-wedge randomised trial in Serrana, Brazil. [PDF]
Borges MC +24 more
europepmc +1 more source
Immunoglobulin G and neutralizing antibody response after CoronaVac. [PDF]
Assis PBC +4 more
europepmc +1 more source

